Sodium Hyaluronate

S

Functions

HumectantSKIN Conditioning

Where is sodium hyaluronate used, and what role does it play in each application?

Sodium hyaluronate functions primarily as a humectant and skin-conditioning agent in cosmetics, but its roles extend to structural and functional applications. In injectable dermal fillers and hydrogels, it acts as a thermoplastic base polymer or cross-linked gel matrix to provide volume and tissue support. It also serves as a shell material in microcapsules for sustained release, a viscoelastic agent in ophthalmic surgery, a lubricant in personal care products, a binder in battery electrodes, and a film-forming component in face masks and dentifrices. This versatility stems from its ability to form networks, absorb water, and interact with other polymers.

Which product or formulation problem does sodium hyaluronate address?

Sodium hyaluronate addresses formulation problems related to moisture retention, structural integrity, and delivery. In cosmetics, it solves dryness and skin conditioning by acting as a humectant. In injectables, it provides volume and physical filling for tissue defects, and cross-linked forms resist enzymatic degradation for longer-lasting effects. It also solves stability issues in emulsions by contributing to viscosity and physical stability, and in microcapsule systems, it enables targeted, sustained release of active ingredients. Additionally, it forms protective barriers in medical sponges to prevent adhesion and in dentifrices to provide lubrication and anti-aging benefits.

What supports the main commercial or clinical uses of sodium hyaluronate?

Evidence for sodium hyaluronate's main uses comes from regulatory classifications and patent filings. The EPA lists it as a polymer of low concern, and the EU has a legal basis under EFSA, supporting its safety for use. In cosmetics, its functions as a humectant and skin conditioner are officially recognized. Patent applications demonstrate a wide range of applications, including dermal fillers, ophthalmic viscoelastics, wound-healing dressings, and moisturizing serums, with specific molecular weight ranges and concentrations claimed for efficacy. However, these patents represent proposed approaches, not proof of commercial adoption or clinical efficacy.

Which formulation trade-offs should researchers consider for sodium hyaluronate?

Key formulation trade-offs for sodium hyaluronate involve molecular weight selection and cross-linking. High molecular weight forms (e.g., 1-2 MDa) provide surface hydration and viscosity, while low molecular weight forms (e.g., 8-20 kDa) may penetrate deeper and offer different sensory properties. Cross-linking enhances resistance to degradation and provides structural support in fillers but may alter viscosity and require careful control of cross-linker residues. Balancing these factors is critical: for example, combining high and low molecular weights can create a gradient effect for both surface and deeper benefits, but may complicate formulation stability. Additionally, achieving physical stability in emulsions may require specific thickeners and viscosity ranges.

Which formulation benchmark best contextualizes sodium hyaluronate, and what differs?

A useful formulation benchmark is the combination of high molecular weight cross-linked hyaluronic acid (≥2000 kDa) with low molecular weight non-cross-linked hyaluronic acid (≤300 kDa), as claimed in cosmetic compositions. This pairing aims to provide both surface hydration and deeper tissue benefits, addressing skin and lip smoothing. In contrast, other formulations may use only non-cross-linked forms with a specific molecular weight range (e.g., 500-1000 kDa) for viscosity and stability, or rely on cross-linked gels for injectable fillers. The key difference lies in the intended function: cross-linked forms prioritize longevity and structure, while non-cross-linked forms focus on hydration and immediate effects.